Systematic integration of molecular profiles identifies miR-22 as a regulator of lipid and folate metabolism in breast cancer cells

Dysregulated microRNA (miRNA) mediate malignant phenotypes, including metabolic reprogramming. By performing an integrative analysis of miRNA and metabolome data for the NCI-60 cell line panel, we identified an miRNA cluster strongly associated with both c-Myc expression and global metabolic variation. Within this cluster the cancer-associated and cardioprotective miR-22 was shown to repress fatty acid synthesis and elongation in tumour cells by targeting ATP citrate lyase and fatty acid elongase 6, as well as impairing mitochondrial one-carbon metabolism by suppression of methylene tetrahydrofolate dehydrogenase/cyclohydrolase. Across several data sets, expression of these target genes were associated with poorer outcomes in breast cancer patients. Importantly, a beneficial effect of miR-22 on clinical outcomes in breast cancer was shown to depend on the expression levels of the identified target genes, demonstrating the relevance of miRNA/mRNA interactions to disease progression in vivo. Our systematic analysis establishes miR-22 as a novel regulator of tumour cell metabolism, a function that could contribute to the role of this miRNA in cellular differentiation and cancer development. Moreover, we provide a paradigmatic example of effect modification in outcome analysis as a consequence of miRNA-directed gene targeting, a phenomenon that could be exploited to improve patient prognosis and treatment.

[1]  Z N Oltvai,et al.  Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells , 2013, Cell Death and Disease.

[2]  V. Mootha,et al.  Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell Proliferation , 2012, Science.

[3]  A. Harris,et al.  How cancer metabolism is tuned for proliferation and vulnerable to disruption , 2012, Nature.

[4]  Ugo Ala,et al.  MicroRNA-Antagonism Regulates Breast Cancer Stemness and Metastasis via TET-Family-Dependent Chromatin Remodeling , 2013, Cell.

[5]  S. Lowe,et al.  A microRNA polycistron as a potential human oncogene , 2005, Nature.

[6]  Johan Trygg,et al.  O2‐PLS, a two‐block (X–Y) latent variable regression (LVR) method with an integral OSC filter , 2003 .

[7]  C. K. Hsiao,et al.  miRSystem: An Integrated System for Characterizing Enriched Functions and Pathways of MicroRNA Targets , 2012, PloS one.

[8]  Stefano Volinia,et al.  Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer , 2013, Proceedings of the National Academy of Sciences.

[9]  Jean-Charles Portais,et al.  IsoCor: correcting MS data in isotope labeling experiments , 2012, Bioinform..

[10]  H. Aburatani,et al.  Tumor suppressor miR-22 determines p53-dependent cellular fate through post-transcriptional regulation of p21. , 2011, Cancer research.

[11]  J. Kelleher,et al.  Acetyl-L-carnitine flux to lipids in cells estimated using isotopomer spectral analysis. , 1997, Journal of lipid research.

[12]  Daniel Eriksson,et al.  Data integration in plant biology: the O2PLS method for combined modeling of transcript and metabolite data. , 2007, The Plant journal : for cell and molecular biology.

[13]  E. Johansson,et al.  Building multivariate systems biology models. , 2012, Analytical chemistry.

[14]  Yang Zhang,et al.  A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis. , 2014, Cancer research.

[15]  Martin M Matzuk,et al.  A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer. , 2010, Molecular endocrinology.

[16]  Peer Bork,et al.  Ancient animal microRNAs and the evolution of tissue identity , 2010, Nature.

[17]  Monica L. Mo,et al.  Global reconstruction of the human metabolic network based on genomic and bibliomic data , 2007, Proceedings of the National Academy of Sciences.

[18]  Tian Yang,et al.  microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity , 2010, British Journal of Cancer.

[19]  Crispin J. Miller,et al.  Simpleaffy: a BioConductor package for Affymetrix Quality Control and data analysis , 2005, Bioinform..

[20]  Kathryn A. O’Donnell,et al.  c-Myc-regulated microRNAs modulate E2F1 expression , 2005, Nature.

[21]  Pascal G. P. Martin,et al.  The key roles of elongases and desaturases in mammalian fatty acid metabolism: Insights from transgenic mice. , 2010, Progress in lipid research.

[22]  P. Grambsch,et al.  A Package for Survival Analysis in S , 1994 .

[23]  V. Mootha,et al.  Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer , 2014, Nature Communications.

[24]  Mark D. Robinson,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[25]  Tsung-Cheng Chang,et al.  c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism , 2009, Nature.

[26]  J. Trygg.  O2‐PLS for qualitative and quantitative analysis in multivariate calibration , 2002 .

[27]  Z. Szallasi,et al.  An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients , 2010, Breast Cancer Research and Treatment.

[28]  C. Croce,et al.  A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis , 2013, Proceedings of the National Academy of Sciences.

[29]  Nathan S. Abell,et al.  A Myc–microRNA network promotes exit from quiescence by suppressing the interferon response and cell-cycle arrest genes , 2013, Nucleic acids research.

[30]  Qing Jing,et al.  Attenuation of MicroRNA‐22 derepressed PTEN to effectively protect rat cardiomyocytes from hypertrophy , 2012, Journal of cellular physiology.

[31]  Minhye Shin,et al.  Mitochondrial MTHFD2L Is a Dual Redox Cofactor-specific Methylenetetrahydrofolate Dehydrogenase/Methenyltetrahydrofolate Cyclohydrolase Expressed in Both Adult and Embryonic Tissues* , 2013, The Journal of Biological Chemistry.

[32]  Alessandro Vespignani,et al.  ATP-Citrate Lyase Links Cellular Metabolism to Histone Acetylation , 2009 .

[33]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[34]  J. Swinnen,et al.  ATP-citrate lyase: a key player in cancer metabolism. , 2012, Cancer research.

[35]  Asaf Levy,et al.  Discovery of microRNAs and other small RNAs in solid tumors , 2010, Nucleic acids research.

[36]  Michael F. Clarke,et al.  Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells , 2009, Cell.

[37]  Nicholas Bertos,et al.  miR-378(∗) mediates metabolic shift in breast cancer cells via the PGC-1β/ERRγ transcriptional pathway. , 2010, Cell metabolism.

[38]  Jon C. Helton,et al.  Survey of sampling-based methods for uncertainty and sensitivity analysis , 2006, Reliab. Eng. Syst. Saf..

[39]  C. Burge,et al.  Most mammalian mRNAs are conserved targets of microRNAs. , 2008, Genome research.

[40]  Anton J. Enright,et al.  Targeted Deletion of MicroRNA-22 Promotes Stress-Induced Cardiac Dilation and Contractile Dysfunction , 2012, Circulation.

[41]  Fang Wang,et al.  An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells , 2013, Science.

[42]  J. Gorodkin,et al.  Global microRNA Analysis of the NCI-60 Cancer Cell Panel , 2011, Molecular Cancer Therapeutics.

[43]  S. Stein.  An integrated method for spectrum extraction and compound identification from gas chromatography/mass spectrometry data , 1999 .

[44]  Kristiina Iljin,et al.  High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion , 2012, Oncotarget.

[45]  J. Kelleher,et al.  Model equations for condensation biosynthesis using stable isotopes and radioisotopes. , 1992, The American journal of physiology.

[46]  K. Artzt,et al.  Mitochondrial C1-Tetrahydrofolate Synthase (MTHFD1L) Supports the Flow of Mitochondrial One-carbon Units into the Methyl Cycle in Embryos* , 2009, The Journal of Biological Chemistry.

[47]  Jacob G. Bundy,et al.  A software complement to AMDIS for processing GC-MS metabolomic data. , 2011, Analytical biochemistry.

[48]  S Badve,et al.  Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22 , 2011, Oncogene.

[49]  P. Domingues,et al.  Fatty acid and phospholipid biosynthetic pathways are regulated throughout mammary epithelial cell differentiation and correlate to breast cancer survival , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[50]  M. Rantalainen,et al.  Statistically integrated metabonomic-proteomic studies on a human prostate cancer xenograft model in mice. , 2006, Journal of proteome research.

[51]  Lai Wei,et al.  Regulation of microRNA expression and abundance during lymphopoiesis. , 2010, Immunity.

[52]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[53]  M. Crescenzi,et al.  Differentiation-associated microRNAs antagonize the Rb–E2F pathway to restrict proliferation , 2012, The Journal of cell biology.

[54]  Yong Li,et al.  A novel miR‐155/miR‐143 cascade controls glycolysis by regulating hexokinase 2 in breast cancer cells , 2012, The EMBO journal.

[55]  Didier Picard,et al.  miR-22 Inhibits Estrogen Signaling by Directly Targeting the Estrogen Receptor α mRNA , 2009, Molecular and Cellular Biology.

[56]  F. Slack,et al.  OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma , 2010, Nature.

[57]  C. Abreu-Goodger,et al.  microRNA-22 Promotes Heart Failure through Coordinate Suppression of PPAR/ERR-Nuclear Hormone Receptor Transcription , 2013, PloS one.

[58]  A. Tomida,et al.  Inhibition of ATP citrate lyase induces triglyceride accumulation with altered fatty acid composition in cancer cells , 2014, International journal of cancer.

[59]  Zicai Liang,et al.  Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein , 2010, Oncogene.

[60]  Gabriela Kalna,et al.  Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase , 2011, Nature.

[61]  T. Shlomi,et al.  Quantitative flux analysis reveals folate-dependent NADPH production , 2014, Nature.

[62]  L. Beretta,et al.  Proteomic and lipidomic signatures of lipid metabolism in NASH-associated hepatocellular carcinoma. , 2013, Cancer research.

[63]  Christian M. Metallo,et al.  Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis , 2012, Nature chemical biology.

[64]  Tsung-Cheng Chang,et al.  Widespread microRNA repression by Myc contributes to tumorigenesis , 2008, Nature Genetics.

[65]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[66]  A. Muñoz,et al.  MicroRNA-22 is induced by vitamin D and contributes to its antiproliferative, antimigratory and gene regulatory effects in colon cancer cells. , 2012, Human molecular genetics.

[67]  Ayellet V. Segrè,et al.  The Lin28/let-7 Axis Regulates Glucose Metabolism , 2011, Cell.

[68]  Aleix Prat Aparicio.  Comprehensive molecular portraits of human breast tumours , 2012 .

[69]  Wei Liu,et al.  Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC , 2012, Proceedings of the National Academy of Sciences.

[70]  M. Robinson,et al.  A scaling normalization method for differential expression analysis of RNA-seq data , 2010, Genome Biology.

[71]  Takashi Takata,et al.  miR-22 represses cancer progression by inducing cellular senescence , 2011, Journal of Cell Biology.

[72]  P. Pandolfi,et al.  The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation. , 2013, Cell stem cell.

[73]  Volker Hovestadt,et al.  Molecular and Cellular Pathobiology MicroRNA Sequence and Expression Analysis in Breast Tumors by Deep Sequencing , 2011 .